SPHERA FUNDS MANAGEMENT LTD. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 143 filers reported holding SAGE THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$6,018,560
-7.5%
128,000
-17.4%
0.94%
-13.5%
Q1 2023$6,503,800
+778.9%
155,000
+1712.0%
1.09%
+1547.0%
Q4 2020$740,000
-94.0%
8,554
-93.3%
0.07%
-95.2%
Q4 2018$12,261,000
+44.7%
128,000
+113.3%
1.38%
+42.0%
Q3 2018$8,475,000
+58.8%
60,000
+85.2%
0.97%
+55.4%
Q4 2017$5,336,000
+904.9%
32,400
+280.4%
0.63%
+734.7%
Q3 2017$531,000
+33.4%
8,518
+70.4%
0.08%
+10.3%
Q2 2017$398,000
-88.8%
5,000
-90.0%
0.07%
-90.2%
Q1 2017$3,554,000
-22.7%
50,000
-44.4%
0.70%
-40.2%
Q4 2016$4,595,000
-37.4%
90,000
-43.6%
1.16%
-2.8%
Q3 2016$7,345,000
+250.8%
159,500
+129.5%
1.20%
+119.9%
Q2 2016$2,094,000
-46.9%
69,500
-43.5%
0.54%
-36.4%
Q1 2016$3,943,000
-27.3%
123,000
+32.3%
0.86%
+7.7%
Q4 2015$5,422,000
+1499.4%
93,000
+1062.5%
0.79%
+1746.5%
Q3 2015$339,000
-90.3%
8,000
-83.3%
0.04%
-87.5%
Q2 2015$3,504,000
+6.1%
48,000
-27.0%
0.34%
-0.3%
Q1 2015$3,301,000
+13.1%
65,724
-17.6%
0.34%
-30.8%
Q4 2014$2,918,000
+5.3%
79,724
-9.3%
0.50%
+45.3%
Q3 2014$2,770,00087,9240.34%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders